Inside this article
A useful treatment journal needs more detail than “I tried Ro.” The product in this entry is Ro Daily Rise Gummies: a daily compounded gummy listing tadalafil 7 mg. Keeping that identity intact lets you distinguish a change in medicine from a change in packaging, service or expectations. The public records provide a starting point; they do not describe your eventual response.
Availability: Public product listing; individual eligibility and current prescription require confirmation.
The exact product
Create a baseline entry before comparing experiences. The distinctive feature of this offer is daily exposure and a gummy dosage form. Write the dispensed name and label details separately from the words in an advertisement. A future change in flavor, strength or ingredients can otherwise disappear behind the same familiar brand name. The fact record below identifies the reviewed listing without recommending a dose or telling you how to administer it.
| Provider | Ro |
|---|---|
| Listed active ingredients | Tadalafil |
| Dosage form | Compounded daily gummy |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | Ro: ED product catalog and plan quantities · Ro: Daily Rise Gummies |
Price, supply and payment
The financial entry should record the payment date as well as the price. For Ro Daily Rise Gummies, the public starting point is $89 monthly or $207 quarterly. Keep a copy of the quantity and commitment attached to your own quote. If you later change products, this record helps distinguish a new prescription charge from a scheduled renewal. It also makes unused supply visible instead of treating every allocated dose as a successful treatment occasion.
| Monthly option | 30 gummies for $89 |
|---|---|
| Quarterly option | 90 gummies for $207 upfront |
| Monthly equivalent | $69 when the $207 quarterly total is divided by three |
| Difference from Sparks | Tadalafil alone; no sildenafil in the listed gummy |
What the research can support
Separate a research note from a personal observation. Here the published evidence concerns approved tadalafil research; no matched gummy-versus-tablet trial verified; it leaves equivalence to an approved daily tablet unresolved. Your experience can be important to a clinician without becoming a controlled comparison. Likewise, a provider survey cannot tell you in advance how you will respond. Record the source and its limits beside the claim so that a memorable headline does not become the entire evidence entry.
| Evidence boundary | approved tadalafil research; no matched gummy-versus-tablet trial verified |
|---|---|
| Not established here | equivalence to an approved daily tablet |
| Clinical and regulatory references | MedlinePlus: Tadalafil · FDA: Compounding and the FDA — questions and answers · DailyMed: Tadalafil prescribing information, including section 5.11 · MedlinePlus: Sildenafil |
Safety questions for the prescriber
The medication-history page belongs next to this product entry. Include other ED medicines, nitrates or nitrites, riociguat, blood-pressure treatment and medicines used only occasionally. Add relevant heart, kidney, liver or eye history. Do not experiment with overlaps or changes to isolate a side effect yourself. For a prescription such as Ro Daily Rise Gummies, an accurate account of what was taken and when is more useful than a guess about the ingredient responsible.
| One active does not mean no interactions | Nitrates/nitrites, riociguat and other medications require assessment even after previous ED treatment. |
|---|
Availability and the actual prescription
Date the access information too. The current documentary finding is: Public product listing; individual eligibility and current prescription require confirmation. A product can remain mentioned online after its enrollment rules change. If an account message differs from an article, save both and ask which applies to the proposed prescription. Do not record a public listing as a completed eligibility decision, and do not mistake a pharmacy dispatch estimate for the whole clinical assessment period.
Refills, changes and cancellation
Keep follow-up entries factual: the original concern, the prescribed product, whether its directions were followed, and the response or unwanted effect. A useful prompt specific to this entry is “What makes this gummy suitable compared with a conventional daily tablet?” Write down the clinician's answer and the plan for reassessment. Billing notes belong alongside this history but do not replace it; postponing a shipment is not necessarily a medical instruction to stop a treatment.
| Order cancellation | Contact support promptly during processing; shipped orders cannot be canceled or returned. |
|---|---|
| Prescription refunds | Generally final; dispensing errors and rejected treatment requests are separate cases. |
| Renewal notice | Use the cutoff disclosed for the selected subscription; no universal ED deadline was verified. |
| Clinical change | The support article states a response within two business days; not independently measured. |
| Policy sources | Ro: terms of use, payments and subscriptions · Ro Support: canceling an order · Ro Support: return and refund policy |
Compare named products
The neighboring reviews are useful for explaining what changed between two offers. Compare a formulation field or payment interval instead of collecting general brand impressions. If you discuss a switch, retain the old entry so the prescriber can see the sequence. Do not translate that sequence into a claim that one product is universally better: symptoms, instructions, concurrent medicines and expectations may have changed as well.
Questions to keep with the offer
A good record includes uncertainty. Mark an unverified current plan or missing study as unverified, rather than filling the space with a testimonial. This entry is based on public documents and is not medically reviewed. We have not obtained Ro Daily Rise Gummies as patients, inspected the supplied medicine or checked individual outcomes. The purpose is to make the next conversation more precise and the written history easier to use.
| Ask about this formula | What makes this gummy suitable compared with a conventional daily tablet? |
|---|---|
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Back to all individual product reviews
The sources behind this page
Public material checked October 7, 2026. Provider pages describe advertised products and terms; they do not independently establish treatment quality.
- Ro: ED product catalog and plan quantitiesProvider catalog; individual products, strengths and plan prices
- Ro: terms of use, payments and subscriptionsProvider policy; distinguish general subscription terms from Ro Body terms
- Ro Support: canceling an orderProvider support; processing orders and future shipments
- Ro Support: return and refund policyProvider support; prescription return and refund restrictions
- Ro Support: changing your prescriptionProvider support; clinical changes and follow-up
- Ro: Daily Rise GummiesProvider source; compounded tadalafil and billing intervals
- MedlinePlus: TadalafilDrug information; standard tadalafil products
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination
- MedlinePlus: SildenafilDrug information; standard sildenafil products